MPZL3: Myelin Protein Zero Like 3

A transmembrane glycoprotein involved in cell adhesion and signaling, with emerging roles in skin biology and cancer.

Gene Information Card

Symbol MPZL3
Full Name myelin protein zero like 3
Gene Type protein-coding
Chromosomal Location 11q23.3
NCBI Gene ID 196264 ncbi.nlm.nih.gov/gene/196264
Ensembl ID ENSG00000175197
UniProt ID Q6UWB1
OMIM ID 611006
HGNC ID 26255
Aliases PZR, PZR3, FLJ22662

Description

MPZL3 (myelin protein zero like 3) encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily. The protein contains a single V-type immunoglobulin-like domain and is involved in cell adhesion, migration, and signal transduction. MPZL3 is expressed in multiple tissues, notably in skin, and has been implicated in hair follicle development, epidermal differentiation, and cancer progression. Alternative splicing generates multiple transcript variants.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Skin disorders (e.g., alopecia, dermatitis) MPZL3 regulates keratinocyte proliferation and differentiation; loss of function disrupts hair follicle cycling and epidermal barrier. Mouse models (knockout) show alopecia and skin inflammation; human expression studies link MPZL3 to psoriasis.
Cancer (e.g., melanoma, breast cancer) MPZL3 modulates cell adhesion and migration; altered expression may promote invasion and metastasis. COSMIC database reports somatic mutations in various cancers; expression changes observed in tumor vs. normal tissue.

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 15.2 Medium
Esophagus 10.8 Medium
Lung 8.5 Low
Breast 7.3 Low
Kidney 6.1 Low
Cell Line Expression
Cell Line nTPM Notes
HaCaT (keratinocyte) 18.4 High expression in skin-derived cells
A549 (lung carcinoma) 9.2 Moderate expression
MCF7 (breast cancer) 6.8 Low expression
HEK293 (embryonic kidney) 5.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.346G>A (p.Gly116Arg) Missense 0.02% (gnomAD) Unknown; predicted possibly damaging
c.487C>T (p.Arg163Trp) Missense 0.01% (gnomAD) Unknown; predicted benign
c.601_602insA (p.Thr201AsnfsTer5) Frameshift Rare Loss of function; truncation
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the protein or disrupt the transmembrane domain are predicted to cause loss of function.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in MPZL3.

Dominant Negative (DN)

No evidence for dominant-negative effects; most mutations are recessive or of unknown significance.

Pathways

• Cell adhesion molecules (CAMs)
• Signaling by Receptor Tyrosine Kinases (via interaction with SHP-2)

Protein Summary

MPZL3 is a single-pass type I transmembrane protein of 242 amino acids. It contains an N-terminal signal peptide, an extracellular immunoglobulin-like V-type domain, a transmembrane region, and a cytoplasmic tail with immunoreceptor tyrosine-based inhibitory motif (ITIM)-like sequences. The protein localizes to the plasma membrane and mediates homophilic and heterophilic cell adhesion. Through its cytoplasmic domain, MPZL3 recruits phosphatases such as SHP-2, modulating downstream signaling pathways involved in cell growth, differentiation, and migration.

Related Products

Product name Cat.No. Species Gene ID
MPZL3 Knockout HEK293 Cell Line EDJ-KQ14294 Human 196264 Details Get a Quote
MPZL3 Knockout A-549 Cell Line EDJ-KQ44352 Human 196264 Details Get a Quote
MPZL3 Knockout HCT 116 Cell Line EDJ-KQ44353 Human 196264 Details Get a Quote
MPZL3 Knockout HeLa Cell Line EDJ-KQ44354 Human 196264 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: